Disynformon
Brand names,
Disynformon
Analogs
Disynformon
Brand Names Mixture
- Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
- Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)
Disynformon
Chemical_Formula
C18H22O2
Disynformon
RX_link
No information avaliable
Disynformon
fda sheet
Disynformon
msds (material safety sheet)
Disynformon
Synthesis Reference
G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)
Disynformon
Molecular Weight
270.366 g/mol
Disynformon
Melting Point
254.5-256 oC
Disynformon
H2O Solubility
3 g/100mL
Disynformon
State
Solid
Disynformon
LogP
4.067
Disynformon
Dosage Forms
Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension
Disynformon
Indication
For management of Menopausal and postmenopausal disorders
Disynformon
Pharmacology
Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.
Disynformon
Absorption
43%
Disynformon
side effects and Toxicity
Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.
Disynformon
Patient Information
Disynformon
Organisms Affected
Humans and other mammals